Written question asked by Preet Kaur Gill (Labour) on Monday, 9 January 2023, in the House of Commons. It was due for an answer on Thursday, 12 January 2023 (named day). It was answered by Andrew Mitchell (Conservative) on Thursday, 12 January 2023 on behalf of the Foreign, Commonwealth and Development Office.

Coronavirus: Vaccination

Question: To ask the Secretary of State for Foreign, Commonwealth and Development Affairs, pursuant to the Answer of 9 December 2022 to Question 95901 on Development Aid: Vaccination, for what reason the estimate of £3.36 per dose was the best available at the time the statistics on vaccine donations were compiled; and for what reason the price Astrazeneca vaccine doses were purchased at was not used.

Answer: The estimate of £3.36 per dose was the best available at the time the statistics on vaccine donations were compiled, as the overall cost to Astrazeneca of developing the vaccinations had not been finalised. Only when all Astrazeneca's expenditures have been taken into account can the final price per dose be reconciled to ensure, as per the contract, that there is no profit and no loss. This reconciliation has now started with the aim to finalise the cost per dose by the end of the 2022/2023 financial year. We will update the final price per date in line with the revisions policy (https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/1021440/FCDO-Revisions-Policy.pdf).

Secondary information

Type: Written question
Reference: 119207
Session: 2022-23
Related items: Development Aid: Vaccination
Friday, 2 December 2022
Written questions
House of Commons
Subjects: Development aid Vaccination Per capita costs AstraZeneca Coronavirus
Link: View this Written question on www.parliament.uk